Methylation-Based Classification of Benign and Malignant Peripheral Nerve Sheath Tumors
You want the tightest possible glycemic management
Coverage criteria for these weight loss medications typically include: A body mass index (BMI) of 30 or higher OR a BMI of 27 or higher with at least one weight-related condition such as high blood pressure, diabetes, or high cholesterol
Do not take tirzepatide if you are pregnant, planning to become pregnant, or breastfeeding
How the Two Medicines Differ Cagrilintide and tirzepatide target different biological signals, so their risks cannot be assessed by looking at one drug alone
Allergic reactions: Signs may include swelling of the face, lips, tongue, or throat, difficulty breathing or swallowing, severe rash or itching, dizziness, or a rapid heartbeat